Vanguard Group
CRBU icon

Vanguard Group’s Caribou Biosciences CRBU Stock Holding History

Vanguard Group’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$6.84M Buy
4,304,198
+77,272
+2% +$162K ﹤0.01% 3138
2025
Q3 		$9.85M Buy
4,226,926
+137,060
+3% +$259K ﹤0.01% 2986
2025
Q2 		$5.15M Sell
4,089,866
-432,166
-10% -$425K ﹤0.01% 3208
2025
Q1 		$4.13M Sell
4,522,032
-43,413
-1% -$56.4K ﹤0.01% 3246
2024
Q4 		$7.26M Sell
4,565,445
-52,823
-1% -$106K ﹤0.01% 3114
2024
Q3 		$9.05M Buy
4,618,268
+73,562
+2% +$151K ﹤0.01% 3007
2024
Q2 		$7.45M Buy
4,544,706
+433,911
+11% +$1.39M ﹤0.01% 3068
2024
Q1 		$21.1M Buy
4,110,795
+148,751
+4% +$917K ﹤0.01% 2570
2023
Q4 		$22.7M Buy
3,962,044
+139,893
+4% +$692K ﹤0.01% 2536
2023
Q3 		$18.3M Buy
3,822,151
+1,261,920
+49% +$7.83M ﹤0.01% 2585
2023
Q2 		$10.9M Sell
2,560,231
-45,830
-2% -$206K ﹤0.01% 2897
2023
Q1 		$13.8M Buy
2,606,061
+25,844
+1% +$161K ﹤0.01% 2768
2022
Q4 		$16.2M Buy
2,580,217
+26,789
+1% +$238K ﹤0.01% 2724
2022
Q3 		$26.9M Buy
2,553,428
+561,065
+28% +$5.23M ﹤0.01% 2499
2022
Q2 		$10.8M Sell
1,992,363
-9,191
-0.5% -$70.3K ﹤0.01% 2952
2022
Q1 		$18.4M Buy
2,001,554
+1,087,038
+119% +$11.5M ﹤0.01% 2824
2021
Q4 		$13.8M Sell
914,516
-21,884
-2% -$426K ﹤0.01% 3050
2021
Q3 		$22.4M Buy
+936,400
New +$22.9M ﹤0.01% 2808

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group's CRBU Position: Q4 2025 in Review

Vanguard Group increased its Caribou Biosciences (CRBU) stake by 1.8% in Q4 2025, buying an estimated $162K and bringing the position to 4,304,198 shares worth $6.84M. The position accounts for ﹤0.01% of the portfolio, ranked #3138.

Vanguard Group first reported a position in CRBU in Q3 2021 and has held it in 18 quarters since. The position peaked at $26.9M in Q3 2022. 124 funds tracked by Wall St. Rank hold CRBU as of Q4 2025.

  • Vanguard Group held 4,304,198 shares of Caribou Biosciences worth $6.84M as of Q4 2025.
  • Vanguard Group bought 77,272 Caribou Biosciences shares in Q4 2025, an estimated $162K.
  • Caribou Biosciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3138 holding.
  • Vanguard Group first reported a position in Caribou Biosciences in Q3 2021 and has held it in 18 quarters since.
  • Vanguard Group's Caribou Biosciences position peaked at $26.9M in Q3 2022.
  • 124 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.